| Acupoints | Beneficial Effects | Potential Mechanisms | Experimental Models Used | Ref. # |
| BL23 | reduce the loss of bone mass, increase femoral BMD, improve the microstructure of bone tissue, promote bone formation, restore the amount of bone volume, improve bone architecture, enhance the secretion of testosterone | Upregulate the ratio of OPG/RANKL and LRP5, β-catenin and Runx2 expression; downregulate the expression of phosphorylated (p)-p38 and p-JNK | rodent models | [4, 35] | BL20 | reduce the loss of bone mass, increase femoral BMD, improve the microstructure of bone tissue | Upregulate the ratio of OPG/RANKL and LRP5, β-catenin and Runx2 expression; downregulate the expression of phosphorylated (p)-p38 and p-JNK | rodent models | [4] | ST36 | increase the tibia BMD, increased E2 levels | Reduced OPGL expression; upregulate the expression levels of RANKL mRNA | Rabbits, rodent models | [36, 37] | GV4 | reduce the loss of bone mass, increase the femoral BMD, improve the microstructure of the bone tissue | Upregulate the ratio of OPG/RANKL expression; upregulate the expression levels of LRP5, β-catenin and Runx2 | rodent models | [38] | SP6 | increase BMD, increased E2 levels | Decrease the concentration of TNFα and IgM | Human body | [7] | CV4 | increase E2 levels, promote the serum ALP level, compress the serum DPD, promote bone formation, decrease the bone absorb, increase the immune function, resist the apoptosis and delay the regressive changes in uterus, strengthen the homeostasis of body | Upregulate the expression levels of ER-α and ER-α mRNA in uterus, hypothalamus and spleen | rodent models | [39, 40] | KI3 | increase BMD, E2 levels | Decrease the concentration of TNFα and IgM | Human body | [7] |
|
|
MD = bone mineral density, JNK = c-Jun N-terminal kinase, OPGL = osteoprotegerin ligand, RANKL = receptor activator of NF-kB ligand, Ig = immunoglobulin, E2 = oestradiol, OPG = osteoprotegerin, TNF = tissue necrosis factor, ALP = alkaline phosphatase, DPD = deoxypyridinoline, ER-α = estrogen receptor-α, LRP = lipoprotein receptor-related protein, Runx = runt-related transcription factor.
|